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DevelopmentInmammals, an array ofMEF2C proteins is generated by alternative splicing (AS), yet speciﬁc functions have not
been ascribed to each isoform. Teleost ﬁsh possess twoMEF2C paralogues, mef2ca and mef2cb. In zebraﬁsh, the
Mef2cs function to promote cardiomyogenic differentiation andmyoﬁbrillogenesis in nascent skeletalmyoﬁbers.
We found that zebraﬁshmef2ca and mef2cb are alternatively spliced in the coding exons 4–6 region and these
splice variants differ in their biological activity. Of the two, mef2ca is more abundantly expressed in developing
skeletal muscle, its activity is tuned through zebraﬁsh development by AS. By 24 hpf, we found the prevalent ex-
pression of the highly active full length protein in differentiated muscle in the somites. The splicing isoform of
mef2ca that lacks exon 5 (mef2ca 4–6), encodes a protein that has 50% lower transcriptional activity, and is
found mainly earlier in development, before muscle differentiation. mef2ca transcripts including exon 5
(mef2ca 4–5–6) are present early in the embryo. Over-expression of this isoform alters the expression of genes
involved in early dorso-ventral patterning of the embryo such as chordin, nodal related 1 and goosecoid, and in-
duces severe developmental defects. AS of mef2cb generates a long splicing isoform in the exon 5 region
(Mef2cbL) that predominates during somitogenesis. Mef2cbL contains an evolutionarily conserved domain de-
rived from exonization of a fragment of intron 5, which confers the ability to induce ectopicmuscle inmesoderm
upon over-expression of the protein. Taken together, the data show that AS is a signiﬁcant regulator of Mef2c
activity.
© 2014 Elsevier B.V. Open access under CC BY-NC-ND license.1. Introduction
Alternative splicing (AS) creates diversity within proteins with-
out the need for gene duplication. In addition, AS is also an important
mechanism for modulating gene expression and has contributed
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Y-NC-ND license.[1–3]). Many transcription factors undergo AS that creates important
functional differences in the encoded proteins: altered transcription-
al regulation capacity, nuclear trafﬁcking, sensitivity to signals or re-
quirement for co-activators [4]. Splicing-sensitive microarrays and
deep sequencing analysis of mRNA from various human tissues
have revealed the prevalence of AS in skeletal muscle; dysregulation
of AS is associated with human muscle diseases [5] (reviewed in [6,7]).
Genes encoding the Myocyte Enhancer Factor 2 (MEF2) family of
transcription factors undergo extensive AS, the function of which is
generally unclear. AllMEF2 proteins have anN-terminal DNAbinding re-
gion composed of MADS (Minichromosome maintenance, Agamous,
Deﬁciens, Serum response factor) and MEF2 domains, two central tran-
scription activating domains (TAD1 and TAD2) and a C-terminal nuclear
localization sequence (Fig. 1B). Invertebrates generally have a single
MEF2 gene, whereas amniotes have four genes (MEF2A-D). The teleost-
speciﬁc genome duplication has led to sixmef2 genes in zebraﬁsh, with
two copies of mef2a andmef2c, designated mef2aa, mef2ab, mef2ca and
mef2cb [8]. Most MEF2 proteins are highly expressed in muscle tissue,
where they regulate the heart, skeletal and smooth muscle differentia-
tion [9]. Like Drosophila D-Mef2, Mef2c is particularly important in
early heart and skeletalmuscle development in bothmice and zebraﬁsh
[8,10–17]. MEF2s are also more broadly expressed and function to
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blood vessel and many other tissues [18] (reviewed in [19]). In mam-
mals,MEF2C is subjected to three different alternative splices. A mutu-
ally exclusive alternative splice occurs between exons α1 and α2,
located in the region immediately adjacent to the MEF2 domain [20].
In the central TAD2 region, a skipping-type alternative splice can
include exon β and a splice involving alternative 3′ splice site selection
occurs in the γ region near the C-terminus [21,22]. In the case of mouse
Mef2d, AS of the α exon switches the protein from a transcriptional re-
pressor regulated by protein kinase A (PKA), to an activator insensitive
to PKA signaling [23]. This switch is thought to drive skeletalmuscle ter-
minal differentiation, but how AS in the Mef2d α exon relatesfunctionally to AS at other alternate exons is unclear. Developmentally
regulated switching of AS of MEF2 genes has been described during
frog andmouse development [24–26]. Involvement of alternative splice
variants ofMef2 in endomesoderm and neuron differentiation in the sea
anemoneNematostella vectensis has been described recently [27]. How-
ever, it has not yet been determined whether functional differences
among the splicing variants of theMEF2C genes are important in verte-
brate development.
Here we describe the alternative splicing of the two zebraﬁshMef2c
genes,mef2ca andmef2cb. In addition to splicing events akin to theα, β,
γ splices thatwere described inmice, we ﬁndnovel splice forms varying
in the region between the two TADs around the ﬁfth coding exon. We
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mef2ca in this region affects Mef2c protein function. We report that
mef2ca transcripts including exon 5 (mef2ca 4–5–6) are expressed
early in development, and their over-expression causes severe defects
in the embryos related to impaired gastrulation that are not created
by variants lacking exon 5. Moreover, ectopic expression of Mef2ca 4–
5–6 results in an increase of the transcript levels of genes such as chordin
(chd), nodal related 1 (ndr1), no-tail a (ntla) and goosecoid (gsc), neces-
sary during gastrulation for correct dorso-ventral patterning. Lastly, we
describe a new evolutionarily conserved alternatively spliced isoform of
mef2cb, here named Mef2cbL, containing an additional octapeptide in
exon 5, that confers on Mef2cb the ability to induce ectopic skeletal
myogenesis.2. Materials and methods
2.1. Plasmids
The full-length coding regions of the zebraﬁsh Mef2ca 4–5–6,
Mef2ca 4–6, Mef2ca 4′–6′ and Mef2cbL variants were ampliﬁed from
24 hpf (hours post fertilization) zebraﬁsh embryos cDNAs. The full
length cDNA of Mef2cbS was obtained by a PCR reaction starting from
a template made of three overlapping PCR products: the exon 5 region
ampliﬁed from a Mef2cb I.M.A.G.E. clone (clone ID: 6519749, GenBank:
CD282884.1), the upstream and downstream regions ampliﬁed from
the Mef2cbL cDNA. The cDNAs were ﬁrst inserted in the pCR2.1 vector
(Invitrogen) or pGEM-T Easy vector (Promega), then sub-cloned into
BamHI/NotI sites of the pcDNA 3.1(+) expression vector (Invitrogen).
For RNA injections isoforms were sub-cloned into the XbaI/SalI sites of
the βUT-3 vector [8]. Plasmids pGL3(desMEF2)3 and pRSVβ-gal were
previously described [28].2.2. Alternative splicing prediction and multiple alignments
TBLASTN (http://blast.ncbi.nlm.nih.gov) was used to predict al-
ternative splicing isoforms of mef2ca or mef2cb and for multiple
alignment to compare mef2cbL sequence to available sequences in
database (GenBank and NCBI Reference sequence are listed in
Fig. S3B). Sequence data were aligned using ClustalW2 (http://
www.ebi.ac.uk/Tools/clustalw2/index.html) and then edited using
GeneDoc software (http://www.psc.edu/biomed/genedoc).2.3. Transcription reporter assays
Transactivation assays were performed by co-transfecting COS-1
cells with indicated expression vectors and cell lysates were analyzed
as described previously [28].Fig. 1. Genomic organization, transcripts and protein variants of zebraﬁshmef2ca andmef2cb g
cated by boxes. Black boxes indicate themef2ca andmef2cb coding exons, whereas gray boxes
translational start codons and the TGA stop codons of the two genes are also indicated. B) Sch
resent UTR, white boxes represent the coding regions of the MADS andMEF2 domains in exons
mef2ca and mef2cb genes transcripts are similar with the following exceptions: mef2ca lacks th
excluded from the mature transcripts, the alternatively spliced γ region overlaps with the hom
it extends to neighboring sequences located in exons 8 and 9;mef2cb transcripts may include a
used to amplify the cDNAs. The structures of the Mef2ca and Mef2cb protein isoforms deduce
proteins comprises theMADS-box and theMEF2 domain, involved in DNA binding and dimeriz
transcriptional activation domains, TAD1 (blue) and TAD2 (orange), encoded respectively by
(squared box). The position of exon 5 (black) and neighboring sequences that are excluded in
Mef2ca andMef2cb respectively. Exon numbering is reported and the number of amino acids is
5 and neighboring regions or the γ-like region are present (Mef2ca 4–5–6, 4–6, 4′–6′, Δ γ-like
region is present or not (Mef2cbL andMef2cbS). C) Details of the alternative splicing events tha
non-canonical splice sites and the three species of mRNA generated; ii. In the γ region ofmef2
alternative 3′ splice site in exon 9 gives rise to the deletion of the γ-like region; iii. Exon 5 regi
natively included inmef2cb transcripts, the competing donor splice sites (GT) and the two spe2.4. RNA isolation, RT-PCR and Real Time PCR
RNA was isolated using TRIzol® Plus RNA Puriﬁcation System
(Ambion). For each developmental stage, 100 embryos were disrupted
using Tissue Raptor (Qiagen). 500 ng of total RNA were reverse tran-
scribed to cDNA using Superscript III reverse transcriptase (Invitrogen).
Primers used to detect myogenin (myog), myod, beta-actin 2 (actb2),
mef2ca and mef2cb are listed in Fig. S6A (other primer sequences are
available upon request), quantitative Real Time PCR (qRTPCR) was per-
formed on 2.5 ng of Poly A mRNA using SYBR Green method (SYBR®
Green PCR Core Reagent, Applied Biosystems). Poly A mRNA has been
puriﬁed using Ambion's protocol (MicroPoly(A) Purist Kit). To amplify
the differentmef2ca isoforms speciﬁc forward primers spanning exon-
exon junctions were used with a common reverse primer (Fig. S6B).
For each primer combination the optimal MgCl2 concentration was de-
termined to obtain speciﬁc and high efﬁcient ampliﬁcation (slope
values between −2.95 and −3.75). Absolute quantiﬁcation of tran-
script copy number was achieved by generating calibration curve
using plasmid DNA templates (listed above) as previously described
[29,30]. Analysis was performed using PCR ABI PRISM 7900 HT Se-
quence Detection System (Applied Biosystems). Student's t-tests were
performed for pairwise comparisons to determine signiﬁcant differ-
ences between groups.
2.5. Zebraﬁsh lines, maintenance and embryo manipulation
Wild-type zebraﬁsh (Danio rerio) lines were maintained on King's
College wild-type background, and staging and husbandry were as
described [31].
2.6. Whole mount in situ hybridization (WISH)
In situ mRNA hybridization was performed as described [14].
Fluorescein- or digoxigenin-tagged probes used were mef2ca [32],
mef2cb [8], myod [33], slow myosin heavy chain 1 (smyhc 1) [8],myo-
sin, light polypeptide 7 (myl7) [34], kinase insert domain receptor
(kdrl) [35], neurogenin 1 (neurog1) [36] or achaete-scute complex-
like 1a (ascl1a) [37]. We have also used two non-overlapping dual
digoxigenin-labelled custom mef2ca exon 5-speciﬁc locked nucleic
acid (LNA) probes, LNA1 and LNA2 (Exiqon, sequence available
upon request) to perform WISH as described [38,39]. Embryos
were photographed as wholemounts on Olympus DP70 or dissected
and ﬂatmounted in glycerol and photographed on a Zeiss Axiophot
with AxioCam using Improvision Openlab.
2.7. mRNA injection and embryo manipulation
mRNA injection was performed as described previously [40]. βUT-3
vectors encoding Mef2ca and Mef2cb isoforms, were linearized using
SﬁI/PstI sites. mRNAs were made with mMESSAGE mMACHINE kitenes. A) Schematics of zebraﬁshmef2ca andmef2cb genes. Exons are numbered and indi-
represent the 5′- and 3′-untranslated regions. Introns are indicated by solid lines. The ATG
ematic representation of zebraﬁshmef2ca andmef2cb transcript variants. Gray boxes rep-
1 and 2, black boxes represent the remaining translated sequence. Structures of zebraﬁsh
e 3α2, exon 5 alone or together with neighboring sequences from exons 4 and 6 may be
ologous γ regions of zebraﬁsh mef2cb and of the other vertebratesmef2c genes, however
short (24 nt) sequence of intron 5 (*). White arrows indicate the position of the primers
d from the cloned cDNA sequences are schematized. The N-terminal region of the Mef2c
ation. By analogy with the mouse and human proteins, in the C-ter there are two putative
exon 4 and by exons 6,7,8, downstream is localized the nuclear localization signal (NLS)
the 4′–6′ isoform (gray) is indicated as well as the position of the γ-like and γ region of
indicated on the bar above.Mef2ca forms are named according towhether or not the exon
). Mef2cb forms are named according to whether or not the octapeptide (*) in the exon 5
t take place respectively: i. In the exon 5 region ofmef2ca, showing the consensus and the
ca, splicing through a non-canonical CA alternative 5′ splice site in exon 8 and a canonical
on ofmef2cb transcript, the cartoon shows the sequence of the intron 5 that can be alter-
cies of mRNA generated.
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25 pg or 50 pg/embryo. Tetramethyl-rhodamine Dextran (5% solution
in 0.2 M KCl) was co-injected in order to sort phenotypes of injected
embryos. At 20–28 hpf injected embryos were analyzed and sorted
using a Zeiss Axiophot with AxioCam.
2.8. Western blot analysis and antibodies
Zebraﬁsh embryos were dechorionated and lysed in RIPA buffer
(50mMTris HCl pH 7.5, 150mMNaCl, 1mMEDTA, 1%NaDeoxycholate,
1% Igepal, 0.1% SDS, 1mMDTT) containing 1mMPMSF and Proteases
Inhibitor Complete cocktail (ROCHE). Equal amounts of protein ex-
tracts were separated by SDS-PAGE and subsequently analyzed by
Western blot as previously described [28]. The following antibodies
were used: rabbit polyclonal anti-MEF2 (sc-313X; Santa Cruz Bio-
technology, Inc.), mouse anti-αTubulin (T6074, Sigma Aldrich),
mouse anti-Vinculin (V4505, Sigma Aldrich). Embryo staining was per-
formedwith a primary antibody against sarcomericmyosin heavy chain
(MyHC; A4.1025 [41]) as previously described [8].
3. Results
To compare alternative splicing inMEF2C genes across species and
paralogues, we use a standard nomenclature numbering exons 5′ to 3′
from the ﬁrst coding exon, yet retaining the conventional α, β, γ desig-
nation for alternatively spliced exons. Each exon number thus corre-
sponds to homologous sequences (Figs. 1A and S1).
3.1. Alternative splicing of zebraﬁsh mef2ca and mef2cb
To predict splice variants of the zebraﬁsh Mef2c proteins, we con-
ducted in silico analysis of the zebraﬁsh mef2ca and mef2cb genes on
public databases (see Materials and methods). In addition to the
knownmef2ca transcript [32,42], we detected two alternative 5′UTR se-
quences and several alternative splices (Fig. 1A and B).mef2ca lacks an
alternative exon 3, the α exon, having a single exon most similar to the
3α1 form of amnioteMEF2C, which has serine residues at positions 98
and 109 [43].Mef2ca contains a putative β exon in intron 6 and, in addi-
tion, a γ-region ﬂanked by a non-canonical 3′ splice site (GC)was found
at the start of exon 9 (Fig. S2A). Of particular note in the in silico analy-
sis, were three alternative splices in the region of exons 4, 5 and 6
(Fig. 1C), two of which correspond to the alternatively spliced δ exon
(exon 5) of themef2c gene product in Xenopus [24] (Fig. S1B,C). By se-
quence alignment we found that splicing of exon 5 is conserved among
teleosts (Fig. S3). Zebraﬁsh mef2cb splicing appeared more similar to
amnioteMEF2C genes than that ofmef2ca. We predicted two 5′ UTR se-
quences, alternate exons 3, 3α1 and 3α2, a putative β exon, encoding
the conserved octapeptide SEDVDLLL in intron 6 ofmef2cb, and a puta-
tiveγ region at the start of exon 9 (Fig. 1B). The sequences of alternative
exons 3α1 and 3α2 are mostly similar to the corresponding alternate
exons of amnioteMEF2C, although neither of the two α exons contains
a PKA target residue corresponding to serine 120 of MEF2D, which was
found to direct binding of repressive or activating cofactors [23]. Addi-
tionally, we found a mef2cb variant with a long exon 5 resulting from
a retained intron 5 sequence. We designate this Mef2cbL to distinguish
it from the conventional exon 5 in Mef2cbS (Fig. 1B, C).
To characterize the major mef2ca and mef2cb spliced isoforms
expressed in developing zebraﬁsh skeletal muscle, we performed RT-
PCR on RNA extracted from the dissected tail region of 24 hpf embryos
using primer pairs that target conserved sequences (Fig. 1B). A series of
mef2ca mRNA RT-PCR products were ampliﬁed, sub-cloned and their
sequences compared to the nucleotide sequence of mef2ca genomic
DNA, revealing the existence of at least four species of mef2camRNAs
produced by AS in developing embryos (Fig. 1B). In addition to the tran-
script encoding the full length protein, here referred to asMef2ca 4–5–6
(465 aa), two mef2ca isoforms, Mef2ca 4–6 (451 aa) and Mef2ca 4′–6′(413 aa) derive, respectively, from skipping exon 5 or a larger region
that also encompasses part of exons 4 and 6. Another variant, Mef2ca
Δγ-like (411 aa) contains exon 5 but lacks the γ region and further se-
quences located in exons 8 and 9. The Mef2ca 4′–6′ andMef2caΔγ-like
mRNAs are the results of splicing at the non-canonical 5′ donor splice
sites GG and CA, respectively (Fig. 1C) (GenBank accession numbers:
KF932282 and KF932281 respectively).
One mef2cb variant, named Mef2cbL, was obtained by RT-PCR; it
includes exon 3α1 and γ but lacks exon β. Mef2cbL arises from the
inclusion of an additional sequence from intron 5 (Fig. 1C). Indeed,
two competing 5′ splice sites are present at the end of exon 5, these
splice sites direct inclusion or exclusion of 24 nucleotides (nt) encoding
the octapeptide KDGIPTYY (Fig. 1C). When aligned (Fig. S2B), the pre-
dicted amino acid sequences of the identiﬁed zebraﬁsh mef2ca and
mef2cb isoforms show that the major variation occurs in the exon 4–
5–6 region of both genes, located between the two TADs described pre-
viously [44,45].
The splicing pattern and the octapeptide sequence of Mef2cbL, ap-
pear to be conserved in other teleosts (Fig. S3). cDNA sequences from
medaka (Oryzias latipes) and caveﬁsh (Sinocyclocheilus anophtalmus
and Sinocyclocheilus angustiporus) have a similar sequence at the end
of intron 5 as in the mef2cbL homologue (Fig. S3). Such sequence con-
servation across the major teleost clades, combined with the location
between TAD1 and TAD2, suggest that AS in the exon 5 region is func-
tionally signiﬁcant.
3.2. mef2ca is the main Mef2c orthologue expressed during skeletal muscle
development
We sought to characterize the temporal and spatial expression pat-
terns of mef2ca and mef2cb in developing zebraﬁsh skeletal muscle.
First, we quantiﬁed the expression levels of mef2ca and mef2cb tran-
scripts by quantitative qRTPCR ampliﬁcation using paralogue-speciﬁc
primers, starting from equal amounts of RNA collected from zebraﬁsh
embryos at sequential developmental stages (from 12 to 72 hpf).
mef2ca and mef2cb presented a similar proﬁle of expression, with a
higher abundance of the transcripts of mef2ca at all stages analyzed.
Both genes were expressed at low levels at 12 hpf (mef2ca 26 copies/
2.5 ng RNA and mef2cb 25 copies/2.5 ng RNA). The total number of
mRNA copies increased by 24 hpf, when theﬁrstmassivewave ofmuscle
ﬁbers differentiates (mef2ca 210/2.5 ng RNA,mef2cb 27/2.5 ng RNA) and
stayed stable at later stages (Fig. 2A). These results were conﬁrmed by
a semi-quantitative PCR experiment (Fig. S4A).
These observations were conﬁrmed by whole mount in situ mRNA
hybridization on developing zebraﬁsh embryos using probes speciﬁc
for eithermef2ca ormef2cb transcripts (Figs. 2B and S4B). At 11 somite
stage (ss),mef2ca andmef2cb transcripts display an overlapping expres-
sion pattern in the adaxial cells next to the notochord and in the bilater-
al heart ﬁelds (Fig. 2B) [8]. At 24 hpf, most mef2ca mRNA is skeletal
muscle-speciﬁc where it follows the expression of myod [14,32]
(Figs. 2B and S4B). In contrast, the transcripts of mef2cb are detected
in the developing heart, blood vessels and telencephalon, as well as
somitic muscle [8] (Figs. 2B and S4B). In summary, mef2ca is the more
abundantly expressed in skeletal muscle of the twoMef2c paralogues.
3.3. Developmentally regulated expression of mef2ca and mef2cb splice
variants
Levels of expression of alternatively splicedmef2ca andmef2cb dur-
ing zebraﬁsh development were determined by semi-quantitative RT-
PCR and qRTPCR RNA quantiﬁcation using SYBR and exon boundary
spanning primers, that allow for selective PCR ampliﬁcation of individ-
ual alternative transcripts [30]. At 12 hpf, the amount of mef2ca 4–6
transcript (lacking exon 5) represents about 30% of the total, whereas
the amount of the full length 4–5–6 transcript the remaining 70%. At
24 hpf and beyond, mef2ca 4–6 expression increased slightly but
Fig. 2. Expression ofmef2ca andmef2cb genes in zebraﬁsh embryos. A) Estimation of ab-
solute mef2ca and mef2cb transcripts by qRTPCR during D. rerio development. The graph
shows transcript-speciﬁc absolute quantiﬁcation, reported as log2 copy number in equal
amount of total RNA (2.5 ng) extracted from zebraﬁsh embryos at 12, 24, 48 and 72 hpf.
Graph showing mean ± SE from four independent experiments, ** and *** indicate P-
values of ≤0.01 and ≤0.001 respectively. B) Wholemount in situ hybridization for
mef2ca and mef2cb mRNA for embryos at 11 ss (dorsal view, anterior to top) and at
24 hpf (lateral view, anterior to left). At 11 ss, both genes are expressed in the adaxial
cells (black arrowheads). By 24 hpf mef2ca is strongly expressed in the myotome (black
arrows) and also in the heart (green arrowhead) and branchial arches (blue arrowhead).
mef2cb transcripts are detected in the heart (green arrowhead), telencephalon (red ar-
rowhead) and are weakly detected in the somites (black arrow). Scale bars = 100 μm.
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increases further (80% of the total mef2ca transcripts) (Fig. 3B–C). The
shortest isoform, mef2ca 4′–6′ is present at low level (less than 1% of
the total mef2ca transcripts) at every developmental stage and was
therefore not considered further. mef2ca transcripts containing the β
exon were barely detectable and were found exclusively at 72 hpf
after ﬁve additional cycles of PCR ampliﬁcation (data not shown). Tran-
scripts without the γ-like region were expressed at early stages of de-
velopment. However, they were less abundant, and were not detected
beyond 24 hpf (Fig. 3A,B). Thus, almost all mef2ca transcripts contain
the γ-like region and lack β exon, irrespective of their splicing at the
4–5–6 region.
Expression of themef2cb alternatively spliced exons was also deter-
mined by semi-quantitative RT-PCR and qRTPCR ampliﬁcation. Tran-
scripts containing exons 3α1 and 3α2 were detected throughout
development using common primers that give two amplicons of differ-
ent size and therefore electrophoretically distinguishable. The transcript
that includes the 3α1 exon is themost abundant at all the developmen-
tal stages beyond 12 hpf (Fig. 3E). This result was also conﬁrmed by
using isoform-speciﬁc primers, given that, in identical experimental
conditions, four additional PCR cycles are required to amplify an amount
of exon 3α2-containing DNA similar to that containing exon 3α1
(Fig. S5A). Whereas the inclusion of exon 3α1 predominates in the de-
veloping embryo, RT-PCR analysis revealed that in adult skeletal and
cardiac muscle the levels of the two isoforms are comparable(Fig. S5B). We did not detect the 3α2-containing transcript in the liver
and brain, indicating a muscle-restricted pattern of expression of this
splice variant, analogously to what has been reported for themammali-
an counterpart (Fig. S5B) [20]. Inclusion of exon βwas barely detected.
In contrast, the γ region and the extra sequence from intron 5
(Mef2cbL) were readily detected at all developmental stages (Fig. 3D,
E). qRTPCR quantiﬁcation conﬁrmed thatmore than 90% ofmef2cb tran-
scripts retain the extra intron 5 sequence, but less than 10% encode the
Mef2cbS form (Fig. 3F). Thus, bothmef2ca andmef2cb show striking var-
iations in the exon 4–5–6 region.
3.4. Exon 5-containing mef2ca transcripts accumulate in skeletal muscle
To examine where mef2ca mRNA(s) that include exon 5 are
expressed in the developing zebraﬁsh embryo, we performed in situ
mRNA hybridization using a probe that recognizes all transcripts
(mef2ca probe, [32]) and two non-overlapping dual digoxigenin-
labelled LNA probes designed to recognize 21 base pair sequences locat-
ed within exon 5 (LNA1) or within the exon 4/5 boundary (LNA2)
(Fig. 4C). In 24 hpf embryos,mef2ca transcripts were detected through-
out the somitic muscle and preferentially observed at somite borders
(Fig. 4A upper panel), as well as in the heart and branchial arches
(Fig. 4A upper panel, see also Fig. 2B). Similarly, both the exon 5-
speciﬁc LNA probes gave signals above background only in skeletal
muscle, preferentially observed at somite borders (Fig. 4A, middle and
lower panels). By 48 hpf, the signals obtained with the generic and
both exon 5-speciﬁc probes, are restricted almost entirely to the somite
boundaries area (Fig. 4B, left and [14]). In addition, signals with all three
probes show the typical separate dorsal and ventralmuscle signal in the
pectoral ﬁn (Fig. 4B, right). Thus, even though we cannot exclude some
levels of expression in other tissues, we conclude that themef2ca 4–5–6
transcript is expressed primarily in skeletal muscle and is mainly local-
ized to somite boundaries, suggesting it may have a distinct and speciﬁc
function.
3.5. Mef2ca 4–5–6 is a potent transactivator
The transcriptional activities of mef2ca splice variants were tested
in vitro by co-transfection into COS-1 cells of each Mef2c splice var-
iant with a MEF2-responsive luciferase reporter containing three
copies of the MEF2 binding site from the Desmin gene regulatory re-
gion (pGL3desMEF2) [46]. COS-1 cells have low endogenous MEF2
expression. Immunoﬂuorescence analysis revealed that all Mef2ca
and Mef2cb splice variants efﬁciently localized to the nucleus (data
not shown), congruent with the observation that they all include
the sequence corresponding to the nuclear localization signal de-
scribed in the mouse [47].
Compared to other Mef2c isoforms tested, the Mef2ca 4–5–6 full
length protein had the strongest transcriptional activity (Fig. 5A). Dele-
tion of amino acids encoded by exon 5 and neighboring sequences re-
sults in a twofold reduction in transcriptional activity, even though the
respective protein expression levelswere comparable (Fig. 5B). Further-
more, we observed that a Mef2ca 4–5–6 isoform lacking the γ-like do-
main had 2-fold higher transcriptional activity than Mef2ca containing
the γ-like domain, consistentwith the ﬁnding that this region represses
transcription (data not shown; [21]). Upon transfection, the Mef2cbL
and Mef2cbS isoforms, each containing both exon 5 and γ, exhibited
similar activity (about 70% of that of Mef2ca 4–5–6) (Fig. 5A and data
not shown). However, Mef2cbL immunoreactivity was much lower
than the Mef2ca isoforms (Fig. 5B). Given that we obtained similar re-
sults with other antibodies directed against different regions of MEF2
proteins (data not shown), it is unlikely that the low amount of
Mef2cb protein detected is due to the low reactivity of our anti-Mef2 an-
tiserum. Additional studies are required to characterize the stability and
translational efﬁciency of Mef2c proteins, but our results suggest that
Mef2cbL has higher activity per molecule than Mef2ca 4–5–6. Taken
Fig. 3.Developmental expression proﬁle ofmef2ca andmef2cb alternative splicingproducts. A) Schematic representation ofMef2ca alternative exons. Arrows showprimers annealing sites
used in the RT-PCR analysis. B) Expression analysis of alternative splicing variants ofmef2ca transcripts by RT-PCR. Total RNA was puriﬁed from staged embryos at 12, 24, 48 and 72 hpf.
PCR was performed using primers that give ampliﬁcation products of different sizes depending on the splice variant. The level of expression of totalmef2ca transcripts was evaluated by
using two primers (ca1 and ca3) that amplify a region not alternatively spliced between exons 1 and 3. Ampliﬁcation of plasmid vectors containing the cDNAs of the variousmef2ca splice
variants cloned into the pcDNA 3.1 vector was used as controls of the correct size of expected amplicons:mef2ca 4–5–6 γ+ (lane 1),mef2ca 4–6 γ+ (lane 2),mef2ca 4′–6′ γ+ (lane 3),
andmef2ca 4–5–6γ- (lane 4). PCR productswere separated in 8%polyacrylamide gels. Length of PCR products in base pairs (bp) is indicated. C) Quantitative analysis of themRNA levels of
mef2ca exon 5 splice variants duringD. rerio development. The amount of the transcripts of each splice variant was estimated by absolute qRTPCR. Original data (mRNA levels of each iso-
form) are reported as % of the total number of mef2ca transcripts (4–5–6 + 4–6 + 4′–6′ = 100%). Statistical analysis was performed on data obtained from three independent experi-
ments, the means ± SE are represented. *** indicates a P-value ≤ 0.001. D) Schematic representations of Mef2cb alternative exons. Arrows show primers annealing sites. E)
Developmental RT-PCR analysis ofmef2cbmRNAs. To evaluate the amount of 3α1- and 3α2-containingmef2cb transcripts, we designed common PCR primers (cb2 and cb4Rv) annealing
to ﬂanking regions in exons 2 and 4 to generate two amplicons of different sizes: a 196-bp (3α1) and a 187-bp (3α2) RT-PCRproducts respectively. Flanking primerswere also designed to
investigate the expression of exon β, the extra sequence of intron 5 (*) and of the γ region. As control templates we used the pcDNA 3.1 expression vector containing the cDNAs of
Mef2cbL3α1 β- γ+ (lane 5), Mef2cbL3α2 β- γ+ (lane 6) andMef2cbS 3α1 β- γ+ (lane 7). actb2was used as a control,myogwas used as a marker for skeletal muscle differentiation.
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TAD2 confers increased activity to Mef2ca.
3.6. Mef2cbL has unique myogenic potential in developing zebraﬁsh
To investigate the biological signiﬁcance of Mef2ca and Mef2cb
splice variants in zebraﬁsh embryonic development, we determined
the effects of their ectopic expression by injecting embryos at the one-
cell stage with synthetic Mef2c mRNAs and analyzing them at 24 hpf.
We have shown previously that injection of mRNA of mef2cb inducesectopic skeletal muscle in embryos [8]. Here we report that injection
of 10 pg/embryo of mRNAs of the Mef2cbL isoform induced ectopic
skeletal muscle in the anterior mesoderm of 40% of the injected embry-
os, as revealed by wholemount in situ hybridization for myodmRNA in
28 hpf zebraﬁsh embryo, a developmental stage where no endogenous
muscle is normally observed in the head (Fig. 6A,B). In addition tomyod
transcripts we detected ectopic expression of smyhc1 transcripts and
MyHC protein, further supporting the pro-myogenic activity ofMef2cbL
(Fig. 6B). No induction of ectopic muscle was observed after ectopically
expressing any Mef2ca isoform, even when higher quantities of mRNA
Fig. 4.WISH analysis of zebraﬁshmef2ca transcripts in developing zebraﬁsh embryos. In situ hybridization usingmef2ca andmef2ca-exon 5 speciﬁc probes as indicated. A) Lateral view of
24hpf embryos.mef2camRNA localizes to both central andperipheral regions of themuscles in the somite, and also to thedevelopingheart and branchial arches (red arrowhead andblack
arrow respectively). Exon 5 speciﬁc transcripts are detected by both LNA probes in a similar way in the muscle, with a slightly stronger expression at somite borders (see insets for mag-
niﬁed somatic muscle area). B, left panels.) Lateral view of 48 hpf embryos, anterior to left. mef2ca general and both LNA1 and LNA2 exon 5-speciﬁc probes show overlapping signals
enriched at ﬁber ends. Right panels.) Dorsal view of the same embryos, anterior to left.mef2ca and both LNA probes detect expression in the pectoral ﬁn dorsal and ventral muscle masses
(black arrowheads). Scale bars = 100 μm. C) Drawing of the LNA1 and LNA2 probes annealing positions within the exon 4/5 region.
Fig. 5. Transcriptional activity of zebraﬁsh Mef2ca and Mef2cb splice variants. A) COS-1
cells were co-transfectedwith pGL3(desMEF2)3 luciferase, the pRSVβ-gal reporter control
and CMV (Cytomegalovirus)-driven expression plasmids encoding for the indicated
Mef2c splicing isoforms. Fireﬂy luciferase activities were normalized for transfection efﬁ-
ciency against the β galactosidase activity and expressed as relative luciferase units of the
activity in cells transfected with the Empty Vector (EV) (=1.0). Statistical analysis was
performed on data obtained from three independent experiments, the means ± SE
(error bars) are represented. *** indicates a P-value ≤0.001. B) Extracts from cells
transfected in panel A were resolved by SDS PAGE, Mef2ca and Mef2cb expression was
assessed by immunoblotting with anti-MEF2 antibody that recognizes all Mef2ca and
Mef2cb splicing isoforms (upper panel). Sample loading was normalized using Vinculin
immunoreactivity (lower panel).
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of the KDGIPTYY octapeptide, because forced expression of theMef2cbS
isoform did not cause ectopic myogenesis (Fig. 6A, B). Thus, the form of
Mef2cb that is normally present in developing zebraﬁsh embryos dur-
ing somitogenesis has unique myogenic potential that is not shared by
Mef2ca 4–5–6, the predominant Mef2c isoform in skeletal muscle. In-
jection of higher amounts (25 pg/embryo) of both Mef2cbS and
Mef2cbL mRNAs resulted in head and trunk developmental alterations
(Fig. 6C).
3.7. Mef2ca 4–5–6 over-expression causes defects in gastrulation
To investigate the functionality of the two main Mef2ca isoforms
expressed during development (Mef2ca 4–5–6 and 4–6), high doses
of Mef2ca mRNAs were employed. Injection of 25 pg of full length
Mef2ca 4–5–6 RNA had dramatic effects on embryonic development,
inducing lethality in approximately 30% of the embryos and marked
developmental defects in 49% of the surviving embryos, classiﬁed as
‘severely defective’ (Fig. S6A,B). Such embryos already had defects
evident at gastrulation stages (6–8 hpf, data not shown). Among
the surviving embryos, a further 34% exhibited a milder phenotype
classiﬁed as ‘defective’, with trunk convergent extension defects, oc-
casional double axes, and some brain defects such as undeveloped
eyes and absence of mid- and forebrain structures (Fig. 7A). Only
16% of embryos appeared unaffected by the Mef2ca 4–5–6 RNA.
The percentage of severely defective embryos increased in a dose-
dependent manner upon increasing the amount of injected RNA
(Fig. S6B). In contrast to Mef2ca 4–5–6, forced expression of the
Mef2ca 4–6 isoform was less active, having no detectable effect on
the development of most (85%) of the injected embryos, even
when expressed at comparable levels to Mef2ca 4–5–6 (Figs. 7A
and S6B,C). These results indicate that ectopic Mef2ca activity in early
stages disrupts normal development. The gross defects in gastrulation
induced by over-expressed Mef2ca 4–5–6 suggested severe tissue pat-
terning disruption, yet a survey of cell lineagemarkers revealed no indi-
cation of altered cell fates at lower doses of RNA (Fig. S6D).
To gain more insight into the mechanisms underlying the ability of
Mef2ca 4–5–6 to disrupt development, the expression levels of genes
encoding transcription factors and signaling molecules that are involved
Fig. 6. Effects of Mef2cbL forced expression in zebraﬁsh embryos. Wholemount in situ mRNA hybridization of zebraﬁsh embryos injected with in-vitro transcribed mRNA
encoding Mef2c isoforms together with Rhodamine dextran at the 1-cell stage. Injected embryos or uninjected control embryos were analyzed during development. A) Myod
mRNA in 22 hpf embryos injected with 25 pg of mef2cb mRNAs. mef2cbL but not mef2cbS injected embryos have ectopic myod expression in head region (arrowheads). Both
groups show an array of developmental defects in the head and trunk regions. B)MyodmRNA in head region at 28 hpf (dorsal view, anterior to top). Injection of 10 pg of Mef2cbL
mRNA induces ectopicmyod expression in headmesoderm (arrowheads). C) smyhc1mRNA and immunoﬂuorescence of MyHC protein in 28 hpf non-injected control embryos or
embryos injected with 10 pg of Mef2cbL mRNA, ectopic muscle is clearly seen in the head region of injected embryos (white arrowheads). While arrow and green arrowhead
indicate somitic muscle and heart respectively. Scale bars = 100 μm.
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RT-PCR. The chd gene, encoding a BMP (Bone Morphogenetic Protein)
antagonist involved in dorsoventral patterning of early embryos [48]
(reviewed in [49,50]), was up-regulated (2-fold) in embryos injected
with the mef2ca 4–5–6 mRNA, but not in those injected with the 4–6
spliced isoform (Fig. 7B,C). Mef2ca 4–5–6 also induced the expression
of ndr1 (1.5-fold), gsc (2.2-fold) and other dorsally-expressed genes
(no-tail a, noggin 1), and reduced the expression of ventralizing factors
such as bmp7a (0.4-fold) andΔnp63 (0.2-fold), but did not alter the tran-
script level ofmyod or no-tail b and bmp2b (Fig. 7B,C), suggesting that the
protein sequence encoded by exon 5 can modulate the expression level
of a speciﬁc subset of early embryonic genes.
3.8. Mef2ca 4–5–6 mRNA is the prevalent Mef2c transcript present in the
embryo before gastrulation
Our data indicate that forced expression ofMef2ca 4–5–6 protein in-
duces the ectopic expression of genes involved in early dorso-ventral
patterning of the embryo. In an attempt to get more insight into a puta-
tive role of Mef2ca in controlling endogenous patterning genes, we next
determined the expression and alternative splicing patterns of mef2c
genes during early stages of development and compared them to
those of two of their putative target genes, i.e. chd and gsc. To this aim
we performed RT-PCR analysis of the RNA from zebraﬁsh embryos har-
vested at the 1K-cell (3 hpf), 50% epiboly (5.25 hpf) and bud (9–10 hpf)
stages. Our analysis revealed thatmef2ca transcripts are already detect-
able as early as at the 1K-cell stage, with predominant expression of the
transcript including exon 5 (Fig. 8).We noticed a rapid loss of the 4–5–6
transcript that became undetectable by 10 hpf when the 4–6 mRNA is
the onlymef2ca transcript detected, inclusion of exon 5 is again detected
later, by 12 hpf (Fig. 3) and the 4–5–6 full length transcript predomi-
nates upon muscle differentiation. The kinetics of expression of themef2ca 4–5–6 transcript suggests that it might be of maternal origin.
The presence of Mef2ca 4–5–6 transcripts early in development,
which is temporally coincident with gsc expression and overlaps par-
tially with that of chd (our data and [51]) is consistent with a role of
this mef2ca splice variant in dorso-ventral patterning. No mef2cb ex-
pression is detected prior to 50% epiboly, in mid-gastrulation, where
only the mef2cbS transcript is present. Nonetheless, at the onset of
somitogenesis (9–10 hpf), we noticed that only the transcript encoding
for Mef2cbL, the pro-myogenic variant, is expressed.4. Discussion
Alternative splicing of transcription factors can have a wide impact
on the regulation of transcriptional networks. However, the relevance
of alternative splicing is often unclear as distinct roles of alternatively
spliced isoforms are often not determined. In this study, we addressed
the functions of alternatively spliced isoforms of zebraﬁsh Mef2ca and
Mef2cb, two transcription factors involved in the development of striat-
ed muscle and head skeletal patterning [8,14,16,42].Mef2cmRNA is al-
ternatively spliced in several organisms [20–22,24,52], and a recent
report suggests that aberrant splice variants of MEF2C are involved in
myogenic disorders [53]. Nevertheless, the functional differences be-
tween alternatively splicedMef2C variants remain elusive. Our ﬁndings
make threemajor points regarding the function of alternative splicing in
Mef2c proteins of teleostﬁsh. Firstly, bothmef2ca andmef2cb gene tran-
scripts undergo speciﬁc alternative splicing and their splicing patterns
change during development. Secondly, splicing of mef2ca transcripts
to include the exon 5 enhances its positive transcriptional activity and
ability to interfere with gastrulation when over-expressed. Thirdly, an
evolutionarily conserved alternate splice of exon 5 inmef2cb transcripts
creates a long form that has unique pro-myogenic capacity.
Fig. 7. Effects of forced expression of mef2ca splice variants on development of zebraﬁsh embryo. A)MyodmRNA in 22 hpf embryos injected with themRNAs of Mef2ca splice variants or
not injected (control). Forced expression of Mef2ca 4–5–6 mRNA resulted in severe developmental defects: double axis (black arrowheads), trunk and brain defects (white arrowheads).
Control embryos or embryos injected with 25 pg of Mef2ca 4–6 mRNA showed normal morphology. B) RT-PCR analysis of the total RNA extracted from 25 pgmef2camRNA injected or
control uninjected embryos at 22 hpf. Mef2ca 4–5–6 injected embryos showed augmented expression of chordin, no-tail a, nodal related 1, noggin 1 and goosecoid, reduced expression of
Δnp63 and bmp 7a, whereas bmp 2b, no-tail b andmyod expression levels are unaffected. C)Densitometric analysis of the bands shown in B, normalized to actb2 signal. Expression levels of
each genewere arbitrarily set to a value of 1 in the uninjected control embryos. Statistical analysiswas performed on data obtained from three independent experiments, themeans± SE
(error bars) are represented. * and ** indicate P-values of ≤0.05 and ≤0.01 respectively.
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development
In addition to the well documented expression of mef2ca starting
from 12 hpf [32], we found mef2ca transcripts in zebraﬁsh embryo
prior to gastrulation at the 1K-cell stage, likely frommaternal contribu-
tion, with their level declining to a minimum at 9–10 hpf. Starting from
12 hpf we observe an overall increase in expression levels of mef2ca
mRNA. Besides changes in the abundance of mef2ca transcripts, we
found a dynamic regulation of the splicing in the exon 5 region: the
mef2ca variant including exon 5 (mef2ca 4–5–6) is the major isoform
detected very early in development (1K-cell stage), suggesting that it
might play a role prior to gastrulation, by 10 hpf, themef2ca transcripts
lacking exon 5 (mef2ca 4–6) are predominant. Subsequently,mef2ca 4–
5–6 again climbs asmuscle precursors undergo terminal differentiation,
becoming the predominant isoform at 24 hpf. Such splicing of exon 5 is
evolutionary conserved between Xenopus and teleosts, suggesting it
has biological signiﬁcance [24] (Fig. S3). Moreover, muscle differentia-
tion in zebraﬁsh is associated with several other muscle-speciﬁc alter-
native splicing events involving changes in splicing efﬁciency [54].
Although no speciﬁc function was assigned to the exon 5 domain by
mutational and deletion analysis of the mouse and human proteincounterparts [44,45], our cell culture data indicate that the peptide
sequence encoded by exon 5 contributes to the transcriptional activ-
ity of Mef2ca. The early expression of mef2ca transcripts including
exon 5 (mef2ca 4–5–6) may indicate their early function in embryo
patterning. Later in development, the preferential accumulation of
full length mef2ca 4–5–6 mRNA at skeletal muscle ﬁber ends, sug-
gests that its normal function is in muscle, a view conﬁrmed by the
requirement for Mef2ca function for skeletal muscle ﬁber growth
and heart myogenesis [8,55]. In the current work the function of
Mef2ca isoforms was probed by ectopic over-expression; mef2ca 4–
5–6 RNA, but not mef2ca 4–6 RNA, causes gross defects during gas-
trulation. We suggest that these effects of Mef2ca 4–5–6 are attribut-
able to its ability to activate, directly or indirectly, a speciﬁc subset of
pivotal genes in gastrulation. We observed the induction in chd (2-
fold) mRNA and a milder (1.4 fold) increase in noggin 1 (nog1)
mRNAs that encode two inhibitors of the BMP signaling. chd is re-
quired to repress bmp2b function in formation of the organizer and
dorsoventral patterning of mesoderm and neural tissue [56–58].
Over-expression of chd dorsalizes embryos [59,60], a phenotype
present in a fraction of embryos following Mef2ca 4–5–6 over-
expression. Thus, up-regulation of these dorsalizing proteins may
explain the effects of Mef2ca 4–5–6.
Fig. 8. Expression of mef2ca and mef2cb splice variants during early zebraﬁsh develop-
ment. Expression levels of the mef2ca and mef2cb splice variants in exon 5 region were
evaluated by RT-PCR analysis of RNA harvested from zebraﬁsh embryos at the indicated
developmental stages. PCR was performed using primers that give ampliﬁcation products
of different sizes depending on the splice variant, as schematized in Fig. 3A. PCR products
were separated in 8% polyacrylamide gels. Length of PCR products is indicated. Expression
levels of gsc and chd were also determined. Expression levels of actb2 RNA are shown as
loading control.
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expression of the Nodal-related 1 (ndr1) gene [61]. In zebraﬁsh,
Mef2ca 4–5–6 over-expression also increases in gsc and ndr1 mRNAs
(2.2- and 1.5-folds, respectively), which regulate dorsoventral pattern-
ing in organisms ranging fromDrosophila tomammals [49,50,62–64]. In
line with our results it has been previously reported that expression of
gsc, is reduced inmef2ca −/− (hoover) mutants [42]. Although we can-
not exclude off-target effects, this speciﬁc ability of Mef2ca 4–5–6, but
not of similar amounts of Mef2ca 4–6, suggests distinct transcriptional
activity of the former. In silico analysis of promoter regions of chd and
ndr1 genes revealed the presence of several putative MEF2 binding
sites (YTA(A/T)4TAR) (data not shown), raising the possibility that
Mef2ca 4–5–6 directly activates their expression during early devel-
opment. Later in development chordin expression may be sustained
by Mef2d, which constitutively includes the sequence encoded by
exon 5, andwhich is expressed frommid-gastrulation in adaxialmuscle
cells that also express chordin [32,60] or by Mef2cb proteins. Interest-
ingly, injection of eithermef2cbS ormef2cbL transcripts, both containing
exon 5, has resulted in similar developmental defects to that of mef2ca
4–5–6 mRNA injection. Future studies will clarify whether these genes
are indeed direct targets of a Mef2 protein containing exon 5.
After gastrulation, zebraﬁshmef2ca transcripts accumulate starting
from12 hpf [14,32], andmef2ca 4–5–6 transcripts are particularly abun-
dant by 24 hpf,We suggest thatMef2ca 4–5–6 functionmightmodulate
chordin and other target gene expression in the somites at later stages
duringmyotome patterning, where later muscle differentiation is regu-
lated by BMP signaling andwhere chordin expression has been observed
[60,65–68].
The protein sequence encoded by exon 5 might represent a binding
motif that mediates protein–protein interactions with speciﬁc co-
factors, as one recognized function for alternatively spliced isoforms is
to remodel the protein–protein interaction network [69]. Supporting
this hypothesis is the recent demonstration that the domains encoded
by the mutually exclusive α1/α2 exons of mouse MEF2D can mediate
interactions with different sets of co-repressors or co-activators [23].
4.2. Gene duplication and evolutionary partitioning of alternative splicing
The importance of other splices inMef2ca remains to be determined.
The γ-like and 4′–6′ splices have low abundance andwewere unable todisplay unique activities for these isoforms. On the other hand, unlike in
mammals, exon 3 does not appear to show alternative splicing in
Mef2ca, the gene only having an α1 version. As the α1 exon of mouse
Mef2D mediates interactions with speciﬁc transcriptional co-
regulators [23], Mef2ca may have a more restricted range of functions
compared to Mef2cb, which retains alternative α exons in its genomic
sequence. However, at the stages examined, transcripts of mef2cb con-
taining the α2 exon had low abundance, suggesting that this splice
may be signiﬁcant in speciﬁc cell types or developmental stages. In
the adult we found a high proportion of themef2cb transcripts contain-
ing the 3α2 exon in striatedmuscle tissue where it might play a speciﬁc
role in mediating muscle gene expression as shown for the analogous
splice variant ofMef2d in mammals [23]. Conversely,mef2cb transcripts
omitting exon 5 were not observed. Instead, teleostmef2cb has evolved
a unique splice, possibly derived by exonisation [1] of a part of intron 5.
The addition of this octapeptide and its conservation across teleosts ap-
pears to have conferred myogenic properties to Mef2cbL.
4.3. Alternative splicing of mef2cb gene generates a pro-myogenic
transcription factor
We detectedmef2cb transcripts in zebraﬁsh embryo as early as 50%
epiboly stage. Mef2cbL is the prevalent Mef2cb isoform starting from 9
to 10 hpf, concomitantly with the onset of somitogenesis and has a
unique pro-myogenic capacity.mef2cbmRNA over-expression can con-
vert cells to skeletal muscle (Fig. 6A; [8]). This result suggests a role for
Mef2 as a skeletal muscle determination factor in zebraﬁsh head, chal-
lenging the classical epistatic relationship between MyoD and MEF2 in
which MyoD acts upstream of MEF2 to direct embryonic multipotent
progenitors into the myogenic lineage. The myogenic activity of
Mef2cbL relies on an octapeptide encoded by a short sequence of intron
5 retained in the transcript. This insert, being too short to form a do-
main,may act by changing the structural fold and leading to a new func-
tion of the protein [70]. Muscle conversion was not observed upon
ectopic expression ofMef2cbL inmouseﬁbroblasts, congruentwith pre-
vious observationsmadewith themouseMEF2 proteins [9,71,72]. Thus,
we propose the existence of a speciﬁc co-factor expressed in zebraﬁsh
headmesoderm that confers myogenic capacity to Mef2cbL. Identifying
Mef2cb'smolecular partners recruited speciﬁcally in the presence of the
octapeptide to activate the expression ofmyod and other muscle genes
may help in deciphering themolecularmechanisms underlying the pro-
myogenic activity of Mef2cbL.
5. Conclusions
Our data reveal novel alternative splicing events around exon 5 of
zebraﬁsh mef2ca and mef2cb transcripts. These various evolutionarily
conserved transcripts expand the transcriptional range of activity of
Mef2c proteins. We propose that by excluding or including sequences
of the exon 5 region, Mef2cs can acquire distinct properties, which
allow them to regulate different sets of target genes and execute unique
developmental programs in vivo.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbagrm.2014.05.003.
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